Role of NKX2-1 in N -bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice

Carcinogenesis

Volumn 30, Issue 9, 2009, Pages 1614-1619

  Hoshi, Sayuri ^a,c   Hoshi, Nobuo ^a,c   Okamoto, Minoru ^a   Paiz, Jorge ^a   Kusakabe, Takashi ^a,d   Ward, Jerrold M ^b   Kimura, Shioko ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Global VetPathology   (United States)

^c TOCHIGI CANCER CENTER   (Japan)

^d Southern Tohoku General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITROLE; BIS(2 HYDROXYPROPYL)NITROSAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.1; UNCLASSIFIED DRUG; CARCINOGEN; NITROSAMINE; NUCLEAR PROTEIN; SULFADIMETHOXINE; THYROID NUCLEAR FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CODON; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; GENOMIC FRAGMENT; GENOTOXICITY; HETEROZYGOSITY; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THYROID ADENOMA; THYROID FOLLICLE CELL; ADENOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; HYPERPLASIA; HYPOPHYSIS; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; THYROID TUMOR;

ADENOMA; AMITROLE; ANIMALS; CARCINOGENS; FEMALE; GENES, RAS; HYPERPLASIA; MALE; MICE; NITROSAMINES; NUCLEAR PROTEINS; PITUITARY GLAND; SULFADIMETHOXINE; THYROID NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 70249105786     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp167     Document Type: Article

References (39)

1. Hurley,P.M. (1998) Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ. Health Perspect. 106, 437-445.
2. Moreira,E.L. et al. (2000) Dose- and sex-related carcinogenesis by N-bis(2-hydroxypropyl)nitrosamine in Wistar rats. Jpn. J. Cancer Res. 91, 368-374.
3. Konishi,Y. et al. (1978) Effect of dose on the carcinogenic activity of orally administered N-bis(2-hydroxypropyl)nitrosamine in rats. Gann, 69, 573-577.
4. Shirai,T. et al. (1984) Dose-related induction of lung, thyroid and kidney tumors by N-bis(2-hydroxypropyl)nitrosamine given orally to F344 rats. Gann, 75, 502-507.
5. Imai,T. et al. (2004) Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation. Toxicol. Pathol., 32, 229-236.
6. Son,H.Y. et al. (2000) Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn. J. Cancer Res., 91, 899-905.
7. Takizawa,T. et al. (2006) Comparison of enhancing effects of different goitrogen treatments in combination with beta-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds. Cancer Sci., 97, 25-31.
8. Yasuhara,K. et al. (2001) Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action. Carcinogenesis, 22, 613-618.
9. Hiasa,Y. et al. (1982) Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis (2-hydroxypropyl)nitrosamine. Carcinogenesis, 3, 1187-1190.
10. Ohshima,M. et al. (1986) Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCr rats. Cancer Res., 46 877-883.
11. Thomas,G.A. et al. (1999) Thyroid stimulating hormone (TSH)-associated follicular hypertrophy and hyperplasia as a mechanism of thyroid carcinogenesis in mice and rats. IARC Sci. Publ., 147, 45-59.
12. Steinhoff,D. et al. (1983) Evaluation of amitrole (aminotriazole) for potential carcinogenicity in orally dosed rats, mice, and golden hamsters. Toxicol. Appl. Pharmacol., 69, 161-169.
13. McClain,R.M. (1989) The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicol. Pathol., 17, 294-306.
14. Kimura,S. et al. (1996) The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev., 10 60-69.
15. De Felice,M. et al. (2004) Thyroid development and its disorders: genetics and molecular mechanisms. Endocr. Rev., 25, 722-746.
16. Damante,G. et al. (2001) A unique combination of transcription factors controls differentiation of thyroid cells. Prog. Nucleic Acid Res. Mol. Biol., 66, 307-356.
17. Kikkawa,F. et al. (1990) Characterization of a thyroid-specific enhancer located 5.5 kilobase pairs upstream of the human thyroid peroxidase gene. Mol. Cell. Biol., 10, 6216-6224.
18. Francis-Lang,H. et al. (1992) Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol. Cell. Biol., 12, 576-588.
19. Civitareale,D. et al. (1989) A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J., 8, 2537-2542.
20. Civitareale,D. et al. (1993) Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol. Endocrinol., 7, 1589-1595.
21. Shimura,H. et al. (1994) Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. Mol. Endocrinol., 8, 1049-1069.
22. Endo,T. et al. (1997) Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/I- symporter gene. Mol. Endocrinol., 11, 1747-1755.
23. Kusakabe,T. et al. (2006) Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. Mol. Endocrinol., 20, 1796-1809.
24. Kusakabe,T. et al. (2004) Thyrocyte-specific expression of Cre recombinase in transgenic mice. Genesis, 39, 212-216.
25. Nolte,T. et al. (2005) Standardized assessment of cell proliferation: The approach of the RITA-CEPA working group. Exp. Toxicol. Pathol., 57, 91-103.
26. Zhang,X. et al. (2007) Basonuclin-null mutation impairs homeostasis and wound repair in mouse corneal epithelium. PLoS ONE 2, e1087.
27. Xue,S. et al. (2009) Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area. J. Diabetes Complicat. (epub ahead of print).
28. Kitahori,Y. et al. (1995) Frequent mutations of Ki-ras codon 12 in N-bis (2-hydroxypropyl)-nitrosamine-initiated thyroid, kidney and lung tumors in Wistar rats. Cancer Lett., 96, 155-161.
29. Kitahori,Y. et al. (1996) G ->. A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine. Cancer Lett., 100, 55-62.
30. Knauf,J.A. et al. (2005) Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res., 65, 4238-4245.
31. Yeager,N. et al. (2007) Pten loss in the mouse thyroid causes goiter and follicular adenomas: Insights into thyroid function and cowden disease pathogenesis. Cancer Res., 67, 959-966.
32. Hoshi,N. et al. (2007) Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology, 148, 4251-4258.
33. Kondo,T. et al. (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer, 6, 292-306.
34. Gudmundsson,J. et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet., 41, 460-464.
35. Lewinski,A. et al. (2007) Genetic background of carcinogenesis in the thyroid gland. Neuro Endocrinol. Lett., 28, 77-105.
36. Kitahori,Y. et al. (1997) Genetic alterations in N-bis(2-hydroxypropyl)nitrosamine-induced rat transplantable thyroid carcinoma lines: Analysis of the TSH-R, G(alpha)s, ras and p53 genes. Carcinogenesis, 18, 265-269.
37. Coxon,A.B. et al. (1998) RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer. Oncogene, 17, 1625-1628.
38. Kroll,T.G. et al. (2000) PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science, 289, 1357-1360.
39. Vasko,V. et al. (2003) Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J. Clin. Endocrinol. Metab., 88 2745-2752.